Israel To Make Concessions To U.S. On Pharma IPR

Law360, New York (April 2, 2004, 12:00 AM EST) -- Israel plans to make concessions to the U.S. on intellectual property issues in the pharmaceutical industry, a senior official told a business newspaper.

“The U.S. knows that we’re planning to change our handling of exclusive data (the exclusive marketing of un-patented drugs) and will fulfill some of their demands, even though there’s no doubt that we have done no wrong,” Minister of Industry, Trade, and Labor Ehud Olmert told business daily “Globes.”

“What’s involved is legitimate use that enables generic drug companies to achieve a position...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.